3349 |
Snare Technique in Retrograde Approach |
Yasushi Asakura |
Apr. 25. 17 |
3348 |
Risk and Benefits for Hybrid CTO PCI: Results from the OPEN CTO Study |
James Aaron Grantham |
Apr. 25. 17 |
3347 |
PeriMI in CTO-PCI: Incidence, Cause, Prevention from ASAN Registry |
Jong-Young Lee |
Apr. 25. 17 |
3346 |
Minimize Residual Plaque: Atherectomy |
Jae-Hwan Lee |
Apr. 25. 17 |
3345 |
Leave Nothing and Suppress Restenosis: Drug-Coated Balloon |
William A. Gray |
Apr. 25. 17 |
3344 |
Biologic and Mechanical Suppression for Restenosis: Drug-Eluting Stent |
Hiroyoshi Yokoi |
Apr. 25. 17 |
3343 |
Complete Sealing for Restenosis: Viabahn Stent |
John Robert Laird, Jr. |
Apr. 25. 17 |
3342 |
Treatment Strategies for Chronic Total Occlusion of SFA |
Donghoon Choi |
Apr. 25. 17 |
3341 |
How to Achieve Reverse CART in the Long CTO? |
Yasumi Igarashi |
Apr. 25. 17 |
3340 |
How to Decide Collateral Availability for Retrograde Route? |
Kazuhiro Ashida |
Apr. 25. 17 |